Obesity, linked to chronic disease, and global warming, linked to climate change, may be indicators of serious problems with our consumption-based economic system
About 15% of the world’s population are now overweight or obese, and this is considered to be a factor in the rising incidence of chronic diseases.1 Excessive carbon concentrations now also exist in the atmosphere (50% higher now than 50 years ago), with implications for the environment and climate disruption.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 School of Health and Human Sciences, Southern Cross University, Lismore, NSW.
- 2 Centre for Health Promotion Research, Sydney, NSW.
- 3 Vascular and Hypertension Unit — Obesity Research, Baker IDI Heart and Diabetes Institute, Melbourne, VIC.
- 4 Department of General Practice, Monash University, Melbourne, VIC.
- 1. James WPT. WHO recognition of the global obesity epidemic. Int J Obes 2008; 32 Suppl 7: S120-S126.
- 2. Intergovernmental Panel on Climate Change. Climate change 2001: synthesis report. New York: Cambridge University Press, 2001. http://www.ipcc.ch/ipccreports/tar/vol4/pdf/front.pdf (accessed Oct 2010).
- 3. Kelishadi R, Cook SR, Motlagh ME, et al. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study. J Am Diet Assoc 2008; 108: 82-90.
- 4. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010; 21: 345-352.
- 5. Hotamisligil GS. Inflammation and metabolic disease. Nature 2006; 444: 860-867.
- 6. Egger G, Dixon J. Should obesity be the main game? Or do we need an environmental makeover to combat the inflammatory and chronic disease epidemics? Obes Rev 2009; 10: 237-249.
- 7. Saremi A, Allison M, Ditomasso D, et al; Veterans Affairs Diabetes Trial. Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus. Metabolism 2010; 59: 430-432.
- 8. Speliotes EK, Masaro JM, Hoffman U, et al. Fatty liver is associated with dyslipiedemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979-1987.
- 9. St George A, Bauman A, Johnston A, et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009; 50: 68-76.
- 10. Egger G, Dixon J. Obesity and chronic disease: always offender or often just accomplice? Br J Nutr 2009; 102: 1238-1244.
- 11. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435.
- 12. Egger G, Dixon J. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010; 11: 137-145.
- 13. Riley JC. Rising life expectancy: a global history. New York: Cambridge University Press, 2001.
- 14. Tapia Granados JA, Ionides EL. The reversal of the relation between economic growth and health progress: Sweden in the 19th and 20th centuries. J Health Econ 2008; 27: 544-563.
- 15. Frenk J, Bobadilla JL, Sepúlveda J, López Cervantes M. Health transition in middle-income countries: new challenges for health care. Health Policy Plan 1989; 4: 29-39.
- 16. Tapia Granados J. Economic growth, business fluctuations and health progress. Int J Epidemiol 2005; 34: 1226-1233.
- 17. Egger G, Swinburn B. Planet obesity: how we are over-eating ourselves and our planet to death. Sydney: Allen and Unwin, 2010.